Transamerica’s term story starts with a choice between price-focused protection and living benefits
Transamerica is one of the easier large insurers to misunderstand because two term policies can look almost identical until the rider package is examined. Trendsetter Super and Trendsetter LB both use level-premium periods of 10, 15, 20, 25 and 30 years, both are issued by Transamerica Life Insurance Company outside New York, and both move to annually increasing premiums after the initial level period. The real decision is what the buyer wants the policy to do while they are alive.
Trendsetter Super is the cleaner protection-first contract. It is designed around a large death benefit, a wide term menu and the ability to convert eligible coverage to permanent insurance without a new medical exam. Trendsetter LB adds accelerated death-benefit features for qualifying critical, chronic and terminal illnesses. Those benefits can be useful, but they change the way the policy should be compared because part of the death benefit may be accessed during life and the amount available depends on the rider terms and the qualifying event.
That distinction is more useful than a generic statement that Transamerica sells “good term insurance.” A healthy parent who mainly wants $1 million of income replacement may care most about the final risk class, premium and conversion privilege. A buyer who places substantial value on living-benefit access may accept a different price or rider structure. The policies solve overlapping but not identical problems.
Transamerica also has permanent and final-expense products, but the term lineup remains the clearest consumer entry point. The company is particularly relevant for shoppers who want five term durations instead of the more common 10-, 20- and 30-year menu and for applicants who may qualify for a nonmedical underwriting path at meaningful face amounts.
Trendsetter Super is a conventional term policy with more duration choice than most competitors
Trendsetter Super currently offers level-premium periods of 10, 15, 20, 25 and 30 years. Transamerica’s consumer materials state that premiums remain level during the selected initial period and then increase annually afterward. The policy is guaranteed renewable to advanced ages under the contract, but that renewal feature should be treated as a backup rather than a long-term pricing plan because annual premiums can rise sharply after the guaranteed period ends.
The 25-year option deserves attention. A household with children, a mortgage or a retirement horizon that sits awkwardly between 20 and 30 years can avoid paying for five extra guaranteed years it does not expect to need. The right term length is the one that matches the financial exposure, not the longest period the insurer is willing to sell.
Transamerica has also promoted Trendsetter Super for accelerated or nonmedical underwriting. Its current consumer field materials state that certain applicants can obtain up to $2 million of coverage without a medical exam at specified ages. That does not mean every applicant receives $2 million without medical evidence. Eligibility remains subject to underwriting, and the company can require additional information when the health history, age, face amount or other risk factors warrant it.
The conversion privilege adds another layer of value. Transamerica states that Trendsetter Super can be converted to permanent life insurance without additional medical underwriting, subject to the contract’s conversion rules. This can become important after a serious health change because the policyholder may preserve access to permanent coverage that would otherwise be difficult to buy. Conversion protects insurability, not the original price. The permanent policy will reflect the insured’s attained age and the product available at conversion.
Trendsetter Super also includes a terminal-illness accelerated death-benefit feature, and optional riders can add benefits such as waiver of premium, child coverage and accidental-death protection depending on jurisdiction. Riders should be evaluated for the risk they address rather than added simply because they are available. A lower base premium can become less meaningful if the quote accumulates riders the household does not need.
Trendsetter LB is about access to the death benefit before death, and that needs careful reading
Trendsetter LB is built around living benefits for qualifying critical, chronic and terminal illnesses. Transamerica’s current materials describe the policy as allowing early access to part of the death benefit after a qualifying event, with benefits that can be used for expenses such as mortgage payments, income replacement, care or medical costs. The money is not restricted to a single category of expense under the rider description, which can make the benefit flexible during a serious illness.
The important limitation is that an accelerated benefit is not a separate pool of insurance sitting beside the death benefit. Amounts paid during life reduce what remains under the policy, and Transamerica states that the amount available can depend on the type and severity of the illness and the insured’s remaining life expectancy. The rider contract controls the calculation. A buyer should not assume that a $1 million death benefit creates a $1 million living-benefit account.
Critical- and chronic-illness definitions also matter. A policy can sound generous in marketing language while using precise medical or functional triggers in the contract. Transamerica’s Trendsetter LB materials make clear that benefits are subject to limitations, exclusions and state variation. Anyone choosing LB specifically for living benefits should review the rider definitions before purchase rather than relying on the phrase “living benefits” as if it were a standardized feature across insurers.
The comparison with standalone health, disability or long-term-care coverage also needs discipline. An accelerated death benefit can provide liquidity after a qualifying event, but it does not replicate the benefit structure of medical insurance, disability-income insurance or a dedicated long-term-care policy. It is life insurance first, with contractual access to part of the death benefit under specified conditions.
Trendsetter LB is therefore most useful when the buyer values that additional access enough to compare the rider mechanics alongside price. If the only goal is inexpensive death-benefit protection, Trendsetter Super may be the cleaner benchmark. If living-benefit protection is central to the plan, LB deserves comparison with other carriers’ definitions and acceleration formulas, not just their headline rider names.
Transamerica’s underwriting can be fast, but most buyers still enter through a professional distribution channel
Transamerica has invested heavily in agent technology and automated underwriting. The company uses electronic applications, tele-interviews and data-based risk assessment across parts of its life portfolio. For qualified term and permanent applicants, the process can avoid traditional laboratory testing or a paramedical exam. More complicated cases can still move into fuller underwriting with additional medical and financial evidence.
That flexibility is useful because it lets the evidence requirement match the case. A healthy applicant seeking a moderate death benefit does not necessarily need the same process as an older applicant with multiple medical conditions or a business owner requesting several million dollars of coverage. Transamerica’s underwriting guides also show that evidence requirements rise with age and face amount, which is normal for life insurance.
The sales experience is not the same as a direct digital insurer. Transamerica distributes heavily through financial professionals and through World Financial Group, an affiliated insurance distribution network that Aegon reported at more than 100,000 agents in the first half of 2026. WFG agents can distribute Transamerica products and products from other insurers. That creates large market reach, but the quality of the consumer experience can depend heavily on the individual producer and how clearly the recommendation is explained.
One unusual term feature is Transamerica’s Income Protection Option. The company describes it as a no-cost option that can structure part of the death benefit as a guaranteed monthly income stream for a period of up to 25 years instead of paying the entire benefit as one lump sum. That can be useful for a policyowner who worries that beneficiaries may struggle to manage a large immediate payment. It is an estate-planning choice about benefit delivery, not extra insurance.
The underwriting result remains more important than application speed. A carrier that gives an instant answer can still be more expensive if it assigns a weaker risk class. Transamerica earns a place in the quote set because of its term design and underwriting reach, but the final issued offer should be compared with competitors before the application experience is treated as a deciding factor.
Transamerica Lifetime is a conventional whole-life contract, not an IUL with a different label
Transamerica Lifetime gives the company a traditional permanent-insurance lane. Current Transamerica product materials describe guaranteed level premiums, guaranteed cash values and a guaranteed death benefit, with standard premium payment to age 100 as well as 10-, 20- and 30-year limited-pay options. Issue ages and available payment periods vary, and the current product guide lists face amounts beginning at $25,000.
That structure is materially different from indexed universal life. Whole life does not depend on an external index-crediting formula for its guaranteed cash-value schedule. The buyer commits to a specified premium pattern, and the contract provides guaranteed values according to that schedule. This can appeal to someone who wants lifetime protection and prefers predictability over flexible funding.
The limited-pay options change the cash-flow decision. Paying premiums over 10, 20 or 30 years can remove the scheduled premium obligation earlier, but doing so generally requires much higher annual premiums than paying to age 100. A buyer should test whether the shorter funding period remains affordable through income changes, market downturns and other financial stress.
Transamerica also offers living-benefit and protection riders on Lifetime, with availability depending on face amount and state. Current materials list chronic-illness, critical-illness, terminal-illness, disability-waiver, children’s coverage and guaranteed-insurability options among the possible riders. A rider can materially change both price and policy behavior, so the quote should identify which features are included rather than treating all Transamerica Lifetime policies as identical.
Whole life is usually a poor substitute for temporary income replacement when the household mainly needs the largest affordable death benefit for 20 or 30 years. It becomes more relevant when the need is genuinely permanent and the buyer values contractual guarantees enough to support the premium. Transamerica’s term reputation should not be used to justify a whole-life policy that fails that separate test.
Final expense is a separate whole-life market, and Transamerica has several ways to approach it
Transamerica maintains a Final Expense Solutions Portfolio built around simplified-issue whole-life coverage. The company’s current online materials identify Immediate Solution, 10-Pay Solution and Easy Solution as distinct products. The portfolio is designed for smaller death benefits intended to help with burial costs, final bills or a modest legacy rather than large income-replacement needs.
The underwriting model is intentionally lighter than a traditional large-face-amount life policy. Transamerica promotes Express Protect Underwriting with an electronic application and the possibility of same-day approval without exams or laboratory testing for qualifying cases. That convenience does not make every final-expense policy guaranteed issue. Health questions, product eligibility and underwriting rules still determine which contract is available.
The products also should not be collapsed into one generic “Transamerica final expense” policy. Immediate Solution, 10-Pay Solution and Easy Solution can differ in premium pattern, benefit structure, face-amount limits and underwriting. The correct comparison names the exact product and asks whether the death benefit is fully available from issue or whether any graded or limited-benefit period applies.
There is a freshness issue worth noting. Transamerica’s public final-expense page still contains an old COVID-era footnote about temporary age restrictions, even though the page continues to describe the product portfolio. That makes the page useful for product architecture but less reliable for current age eligibility. Current quotes and policy-specific underwriting materials should control any age or face-amount decision rather than an old temporary footnote.
Final-expense buyers should also compare whether they can qualify for a medically underwritten or simplified whole-life policy with stronger immediate benefits before choosing the easiest application. The simplest underwriting route can be appropriate when health limits the alternatives. It should not become the default merely because the application is shorter.
Financial Foundation IUL can support permanent planning, but the guarantee and the illustration need separate attention
Transamerica Financial Foundation IUL is the company’s long-running indexed universal-life platform. Current Transamerica product materials list issue ages extending as high as 85 for certain classes, a minimum face amount of $25,000 and multiple account choices that include an S&P 500-linked account, a global index account and a basic interest account. The policy also offers no-lapse protection when the required cumulative minimum premium conditions are satisfied.
The no-lapse feature is important because IUL otherwise combines flexible premiums with policy charges that continue over time. Current product materials state that the no-lapse period can extend for the lesser of 20 years or to age 65 for younger issue ages, while older issue ages receive a shorter period. After that guarantee ends, or if the required premium test is not met, the policy value and future funding become more important to keeping coverage in force.
Financial Foundation IUL also offers optional living-benefit riders, including chronic-, critical- and terminal-illness benefits and, in eligible cases, a long-term-care rider. The LTC rider has its own qualification rules and can affect loans, withdrawals and the death benefit while a claim is being paid. It should be evaluated as a separate contractual feature rather than assumed to turn the IUL into a complete long-term-care plan.
The index accounts do not invest policy value directly in the stock market. Interest is credited according to the contract’s formula, subject to caps, floors, participation rules and other terms. Transamerica’s current guide lists guaranteed minimum crediting provisions for certain accounts, but policy charges continue regardless of credited interest. A positive floor on the index-crediting formula does not guarantee that the total policy value will never decline.
Loans and withdrawals add another variable. Permanent policy value can provide access to cash, but borrowing reduces available value and can reduce the death benefit. If a policy is heavily borrowed or underfunded, the risk of lapse can increase, and lapse with outstanding gain can create tax consequences. An IUL sold primarily as a future income strategy should therefore be tested under lower crediting assumptions and higher funding stress, not judged only by the current illustrated column.
Transamerica also maintains variable-life infrastructure and prospectus materials for in-force business, but at least one older VUL product is explicitly closed to new sales. That is another reason to use current new-business product documents rather than treating every policy visible in a legacy portal as a current retail option.
Financial strength is adequate for a major carrier, but the service data deserves equal attention
AM Best affirmed an A (Excellent) Financial Strength Rating for Transamerica Life Insurance Company and Transamerica Financial Life Insurance Company on February 13, 2026, with a stable outlook. AM Best said the ratings reflect a very strong balance-sheet assessment, strong operating performance, a favorable business profile and appropriate enterprise risk management for the Aegon USA group.
That current rating is important because an older Transamerica financial-overview page still displays an A+ AM Best rating with an effective date in 2011. The newer AM Best action is the appropriate current source. A life insurer’s ratings can change over time, and a company page that clearly labels an old effective date should not be treated as a current rating merely because it remains online.
Customer satisfaction tells a less comfortable story. Transamerica scored 604 in J.D. Power’s 2025 U.S. Individual Life Insurance Study, compared with a study average of 650. The study measured trust, value for price, ease of doing business, people, product offerings, service availability, problem resolution and digital channels. The score placed Transamerica near the bottom of the ranked group.
That result does not prove that a particular claim or service interaction will go badly. It does mean the provider-level evaluation should not rely on product design and financial strength alone. A term policy can remain in force for decades, and a whole-life or IUL relationship can last a lifetime. Beneficiary changes, premium questions, conversions, policy loans and claims all create service moments long after the original sale.
Aegon is simultaneously investing heavily in Transamerica’s U.S. growth. In its first-half 2026 results, Aegon said Transamerica individual-life sales increased 54% from the prior-year period, driven in part by growth in the instant-decision market. Commercial momentum shows that the platform is expanding. It does not answer the customer-experience question, which should remain visible beside the sales growth.
The Transamerica name still leads to two legal insurers, and New York changes the map
Transamerica Life Insurance Company is domiciled in Iowa and is licensed in the District of Columbia and every state except New York. Transamerica Financial Life Insurance Company is the affiliated insurer used for New York business. Both companies sit within the Aegon group, but each legal insurer is responsible for the obligations of the contracts it issues.
This distinction is particularly important because Trendsetter Super and Trendsetter LB are not available in New York in their current Transamerica Life Insurance Company forms. A New York resident cannot assume that the same product, rider or quote shown on a national Transamerica page is available through TFLIC. The New York product form and issuing company have to be checked separately.
Transamerica has legitimate product strengths: five term durations, a living-benefit term option, meaningful nonmedical underwriting capacity, traditional whole life, final-expense coverage and a mature IUL platform. It also has a weaker recent satisfaction result than many major competitors and an online information ecosystem where older pages can sit beside current material. That makes source freshness and exact product identification unusually important.
A clean Transamerica recommendation should be specific enough to name the policy, underwriting result and legal issuer. Trendsetter Super can win a term case because of price, duration or conversion. Trendsetter LB can win because the living-benefit definitions matter to the buyer. Lifetime can make sense for a permanent guarantee. Financial Foundation IUL can serve a different objective entirely. The company review is useful for orienting the shopper, but the final decision belongs to the contract.